Publicado

2015-10-01

Guía de práctica clínica sobre diagnóstico y tratamiento de infección de vías urinarias no complicada en mujeres adquirida en la comunidad

Clinical practice guidelines for the diagnosis and treatment of community-acquired uncomplicated urinary tract infections in women

Palabras clave:

Infecciones urinarias, Guías de práctica clínica como asunto, Cistitis, Pielonefritis, Terapia (es)
Urinary tract infections, Practice Guidelines as Topic, Cystitis, Pyelonephritis, Cystitis/Therapy, Pyelonephritis/Therapy. (en)

Descargas

Autores/as

  • Jorge Alberto Cortés Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Departamento de Medicina Interna -Bogotá, D.C. - Colombia.
  • Diego Perdomo Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Departamento de Medicina Interna -Bogotá, D.C. - Colombia.
  • Renán Morales Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Departamento de Medicina Interna -Bogotá, D.C. - Colombia.
  • Carlos Arturo Álvarez Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Departamento de Medicina Interna -Bogotá, D.C. - Colombia. Clínica Universitaria Colombia, Clínica Colsanitas - Bogotá, D.C. - Colombia.
  • Sonia Isabel Cuervo Clínica Universitaria Colombia, Clínica Colsanitas - Bogotá, D.C. - Colombia.
  • Aura Lucía Leal Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Departamento de Microbiología -Bogotá, D.C. - Colombia.
  • Julio César Gómez Asociación Colombiana de Infectología - Capítulo Central - Bogotá, D.C. - Colombia.
  • Patricia Reyes Clínica Universitaria Colombia, Clínica Colsanitas - Bogotá, D.C. - Colombia.
  • Análida Elizabeth Pinilla Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Departamento de Medicina Interna -Bogotá, D.C. - Colombia. Asociación Colombiana de Medicina Interna - Bogotá, D.C. - Capítulo Central.
  • Edgar Castellanos Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Departamento de Cirugía -Bogotá, D.C. - Colombia.
  • Wilfredo Donoso Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina - Departamento de Cirugía -Bogotá, D.C. - Colombia.

Mediante un proceso de adaptación de guías de práctica clínica se seleccionaron y evaluaron guías de infección de vías urinarias en mujeres premenopáusicas no embarazadas; se identificaron 3 de alta calidad. Con base en las evidencias y las recomendaciones aportadas por estas guías, se realizó un consenso para realizar recomendaciones para personal de salud -médicos, personal de laboratorio y enfermeros- sobre el diagnóstico de las infecciones urinarias -cistitis y pielonefritis-, sus tratamientos y prevención de la recurrencia.

Using a process of adaptation, guidelines for the diagnosis, treament and prevention of urinary tract infection in premenopausal non-pregnant women were chosen and assessed. Three high quality guidelines were identified. Based on the evidence that supported these guidelines and their recommendations, a consensus was made to do recommendations for healthcare workers (physicians, laboratory personnel and nurses) on the diagnosis of urinary tract infections (cystitis and pyelonephritis), their treatment and the prevention of recurrence.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am. 2003;17(2):227-41. http://doi.org/c2h2qj.

Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol. 2000;151(12):1194-205. http://doi.org/63c.

Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect. 2009;58(2):91-102. http://doi.org/czv5pd.

Leal AL, Cortes JA, Arias G, Ovalle MV, Saavedra SY, Buitrago G, et al. Emergencia de fenotipos resistentes a cefalosporinas de tercera generación en Enterobacteriaceae causantes de infección del tracto urinario de inicio comunitario en hospitales de Colombia. Enferm Infecc Microbiol Clin. 2013;31(5):298-303. http://doi.org/f2jttq.

Martínez P, Garzón D, Mattar S. CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia. Braz J Infect Dis. 2012;16(5):420-5. http://doi.org/f2j8jn.

Hoyos A, Serna L, Ortiz G, Aguirre J. Infección urinaria adquirida en la comunidad en pacientes pediátricos: clínica, factores de riesgo, etiología, resistencia a los antibióticos y respuesta a la terapia empírica. Infectio. 2012;16(2):94-103. http://doi.org/63d.

Ruiz SJ, Montealegre MC, Ruiz-Garbajosa P, Correa A, Briceno DF, Martínez E, et al. First characterization of CTX-M-15-producing Escherichia coli ST131 and ST405 clones causing community-onset infections in South America. J Clin Microbiol. 2011;49(5):1993-6. http://doi.org/bjxtzj.

Gómez C, Plata M, Sejnaui J, Rico-Villegas C, Vanegas-Gonzáles S. Resistencia de la E.coli en urocultivos de pacientes con sospecha de infección urinaria intra y extra-hospitalaria en la Fundación Santa Fe de Bogotá. Urol Colomb. 2009;18(1):53-8.

Caicedo P, Martínez T, Meneses E, Joaqui W, Imbachi R, Mahe D, et al. Etiología y resistenciabacteriana en infecciones de vías urinarias en el Hospital Universitario San Jose de Popayan, Colombia entre enero y diciembre de 2008. Urol Colomb. 2009;18(3):45-52.

Álvarez-Barranco L. Infecciones de vías urinarias en el Hospital Universidad del Norte. Salud Uninorte. 2007;23:9-18.

Murillo-Rojas OA, Leal-Castro AL, Eslava-Schmalbach JH. Uso de antibióticos en infección de vías urinarias en una unidad de primer nivel de atención en salud, Bogotá, Colombia. Revista de salud pública. 2006;8:170-81. http://doi.org/dhnxfr.

Appraisal of Guidelines Research and Evaluation. Instrumento AGREE II: instrumento para la evaluación de guías de práctica clíníca. Consorcio AGREE; 2009.

Martínez E, Osorio J, Delgado J, Esparza G, Motoa G, Blanco VM, et al. Infecciones del tracto urinario bajo en adultos y embarazadas: Consenso para el manejo empírico. Infectio. 2013;17:122-35. http://doi.org/f2pmpr.

Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2010;52(5):e103-20.

Andre M, Mölstad S, Lundborg CS, Odenholt I. Management of urinary tract infections in primary care: a repeated 1-week diagnosis-prescribing study in five counties in Sweden in 2000 and 2002. Scand J Infect Dis. 2004;36(2):134-8. http://doi.org/b8xtnm.

Skerk V, Andrasevic AT, Andrasevic S, Susic E, Dzepina AM, Madaric V, et al. ISKRA guidelines on antimicrobial treatment and prophylaxis of urinary tract infections-Croatian national guidelines. Lijec Vjesn. 2009;131(5-6):105-18.

de Meyrick J. The Delphi method and health research. Health Education. 2003;103(1):7-16. http://doi.org/c597sd.

Sánchez-Pedraza R, Jaramillo-González LE. Metodología de calificación y resumen de las opiniones dentro de consensos formales. Revista Colombiana de Psiquiatría. 2009;38(4):777-85.

Castillejo MM, Zulaica CV. Calidad de la evidencia y grado de recomendación. MBE Series Guías Clínicas. 2007;1(6).

Williams GJ, Macaskill P, Chan SF, Turner RM, Hodson E, Craig JC. Absolute and relative accuracy of rapid urine tests for urinary tract infection in children: a meta-analysis. Lancet Infect Dis. 2010;10(4):240-50. http://doi.org/b3mm43.

López-Vargas JA, Cuartas-Trujillo MC, Molina-Upegui OL, Restrepo-Ceballos AC, Maya-Carmona CY, Jaramillo-Velásquez S, et al. Utilidad del citoquímico y la coloración de Gram en muestras de orina en el diagnóstico de las infecciones del tracto urinario en pacientes hospitalizados. Iatreia. 2005;18(4):377-84.

Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med. 1982;307(8):463-8. http://doi.org/cm835t.

Secretaria Distrital de Salud de Bogotá, D.C. Manual para la toma de muestras para análisis microbiológico. Bogotá, D.C.: Editorial Linotipia Bolívar; 2008.

Hurlbut TA 3rd, Littenberg B. The diagnostic accuracy of rapid dipstick tests to predict urinary tract infection. Am J Clin Pathol. 1991;96(5):582-8.

ACOG Practice Bulletin No. 91. Treatment of urinary tract infections in nonpregnant women. Obstet Gynecol. 2008;111(3):785-94. http://doi.org/fn8gnv.

Kass EH. Bacteriuria and pyelonephritis of pregnancy. Arch Intern Med. 1960;105(2):194-8. http://doi.org/fxhkrr.

Machado-Alba JE, Murillo-Muñoz MM. Evaluación de sensibilidad antibiótica en urocultivos de pacientes en primer nivel de atención en salud de Pereira. Revista de salud pública. 2012;14:710-9.

Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med. 2007;167(20):2207-12. http://doi.org/cnnknj.

Iravani A, Klimberg I, Briefer C, Munera C, Kowalsky SF, Echols RM. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother. 1999;43(Suppl A):67-75. http://doi.org/b94zg4.

Christiaens TC, De Meyere M, Verschraegen G, Peersman W, Heytens S, De Maeseneer JM. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract. 2002;52:729-34.

Vree TB, Hekster YA, Baars AM, Damsma JE, van der Kleijn E, Bron J. Determination of nitrofurantoin (Furadantine) and hydroxymethylnitrofurantoin (Urfadyn) in plasma and urine of man by means of high-performance liquid chromatography. Journal of chromatography. 1979;162(1):110-6. http://doi.org/djftjg.

Minassian MA, Lewis DA, Chattopadhyay D, Bovill B, Duckworth GJ, Williams JD. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women. Int J Antimicrob Agents. 1998;10(1):39-47. http://doi.org/df2nhg.

Ceran N, Mert D, Kocdogan FY, Erdem I, Ozyurek S, Goktas P, et al. A randomized comparative study of single-dose fosfomycin and 5-day ciprofloxacin in female patients with uncomplicated lower urinary tract infections. J Infect Chemother. 2010;16(6):424-30. http://doi.org/d2k3bp.

Stein GE. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther. 1999;21(1):1864-72. http://doi.org/d7v7ds.

Hooton TM, Scholes D, Gupta K, Stapleton AE, Roberts PL, Stamm WE. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA. 2005;293(8):949-55. http://doi.org/czcrpj.

Naber KG, Koch EM. Cefuroxime axetil versus ofloxacin for short-term therapy of acute uncomplicated lower urinary tract infections in women. Infection. 1993;21(1):34-9. http://doi.org/ct6m3n.

Menday AP. Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection. Int J Antimicrob Agents. 2000;13(3):183-7. http://doi.org/dqknmz.

Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, et al. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis. 2002;34(9):1165-9. http://doi.org/c3wjks.

Henry DC, Bettis RB, Riffer E, Haverstock DC, Kowalsky SF, Manning K, et al. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin Ther. 2002;24(12):2088-104. http://doi.org/dvz72h.

Fourcroy JL, Berner B, Chiang YK, Cramer M, Rowe L, Shore N. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women. Antimicrob Agents Chemother. 2005;49(10):4137-43. http://doi.org/fcmqhq.

Arredondo-García JL, Figueroa-Damian R, Rosas A, Jauregui A, Corral M, Costa A, et al. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. J Antimicrob Chemother. 2004;54(4):840-3. http://doi.org/bqjhz8.

Peterson J, Kaul S, Khashab M, Fisher AC, Kahn JB. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology. 2008;71(1):17-22. http://doi.org/dsngr4.

Naber KG, Allin DM, Clarysse L, Haworth DA, James IG, Raini C, et al. Gatifloxacin 400 mg as a single shot or 200mg once daily for 3 days is as effective as ciprofloxacin 250mg twice daily for the treatment of patients with uncomplicated urinary tract infections. Int J Antimicrob Agents. 2004;23(6):596-605. http://doi.org/cvmqdx.

Sánchez-Ramos L, McAlpine KJ, Adair CD, Kaunitz AM, Delke I, Briones DK. Pyelonephritis in pregnancy: once-a-day ceftriaxone versus multiple doses of cefazolin. A randomized, double-blind trial. Am J Obstet Gynecol. 1995;172(1):129-33. http://doi.org/d94kqp.

Sánchez M, Collvinent B, Miro O, Horcajada JP, Moreno A, Marco F, et al. Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial. Emerg Med J. 2002;19(1):19-22. http://doi.org/b6xtxv.

Hooton TM. Uncomplicated urinary tract infection. N Engl J Med. 2012;366:1028-37. http://doi.org/63g.

Stein GE, Christensen S, Mummaw N. Treatment of acute uncomplicated urinary tract infection with ceftibuten. Infection. 1991;19(2):124-6. http://doi.org/bpjspd.

Pigrau C. Infección del tracto urinario. Barcelona: Ergón; 2013.

Hu KK, Boyko EJ, Scholes D, Normand E, Chen CL, Grafton J, et al. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med. 2004;164(9):989-93. http://doi.org/dx5b9b.

Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents. 2001;17(4):259-68. http://doi.org/dxnh75.

Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182(4):1177-82. http://doi.org/drj3sd.

Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10:CD001321. http://doi.org/63h.

Albert X, Huertas I, Pereiro, II, Sanfelix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev. 2004;3:CD001209. http://doi.org/ds7mqp.

Stapleton A, Latham RH, Johnson C, Stamm WE. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA. 1990;264(6):703-6. http://doi.org/fmpbvh.

Melekos MD, Asbach HW, Gerharz E, Zarakovitis IE, Weingaertner K, Naber KG. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. J Urol. 1997;157(3):935-9. http://doi.org/cswckb.

Gupta K, Hooton TM, Roberts PL, Stamm WE. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med. 2001;135(1):9-16. http://doi.org/63j.

Schaeffer AJ, Stuppy BA. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol. 1999;161(1):207-11. http://doi.org/b9tjsc.

Licencia

Derechos de autor 2015 Revista de la Facultad de Medicina

Creative Commons License

Esta obra está bajo una licencia Creative Commons Reconocimiento 3.0 Unported.

-